FIELD: biology.
SUBSTANCE: invention relates to biology and genetic engineering. Disclosed is an isolated peptide for therapeutic purposes, containing a sequence at least 95% identical to SEQ ID NO: 4 (GG00444), or its fragment or variant, capable of binding with human bowel mucus, as well as fimbriated structure comprising same, food product, pharmaceutical composition, polynucleotide, expression vector, host cell, gene cluster, antibody, method of treatment and method of screening probiotic bacterial strains.
EFFECT: treatment of intestinal diseases.
33 cl, 11 dwg, 2 tbl, 11 ex
Authors
Dates
2016-05-10—Published
2010-02-02—Filed